GSK Offers $28M To Settle Suits Over Defective Paxil

By Melissa Lipman · March 2, 2009, 12:00 AM EST

GlaxoSmithKline PLC has agreed to pay $28 million to settle two proposed class actions over claims that the company's Puerto Rico plant produced defective versions of the company's antidepressant Paxil CR...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Simonet v. GlaxoSmithkline et al

Case Number

3:06-cv-01230

Court

Puerto Rico

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

March 06, 2006